479685-13-7 Usage
Uses
Used in Medicinal Chemistry:
1-Boc-4-(3-amino-6-bromopyrazin-2-yl)piperazine is used as a key intermediate in the synthesis of new drug candidates for the treatment of various diseases. Its unique structural features and chemical reactivity allow for the development of innovative therapeutic agents with improved efficacy and selectivity.
Used in Drug Development:
1-Boc-4-(3-amino-6-bromopyrazin-2-yl)piperazine is employed as a building block in the design and synthesis of novel pharmaceutical compounds. Its versatility and compatibility with various chemical reactions enable the creation of new drug candidates with potential therapeutic benefits.
Used in Research and Development:
1-Boc-4-(3-amino-6-bromopyrazin-2-yl)piperazine is utilized in research and development efforts aimed at discovering new therapeutic agents based on its chemical scaffold. Further studies and exploration of its properties may lead to the identification of novel drug candidates with improved pharmacological profiles and therapeutic potential.
Check Digit Verification of cas no
The CAS Registry Mumber 479685-13-7 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 4,7,9,6,8 and 5 respectively; the second part has 2 digits, 1 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 479685-13:
(8*4)+(7*7)+(6*9)+(5*6)+(4*8)+(3*5)+(2*1)+(1*3)=217
217 % 10 = 7
So 479685-13-7 is a valid CAS Registry Number.
InChI:InChI=1/C13H20BrN5O2/c1-13(2,3)21-12(20)19-6-4-18(5-7-19)11-10(15)16-8-9(14)17-11/h8H,4-7H2,1-3H3,(H2,15,16)
479685-13-7Relevant academic research and scientific papers
Aminopyrazine analogs for treating glaucoma and other rho kinase-mediated diseases and conditions
-
Page/Page column 16, (2008/06/13)
Methods for using aminopyrazine analogs to treat rho kinase-mediated diseases or rho kinase-mediated conditions, including controlling intraocular pressure and treating glaucoma, are disclosed. Ophthalmic pharmaceutical compositions useful in the treatment of eye diseases such as glaucoma, and additionally useful for controlling intraocular pressure, the compositions comprising an effective amount of aminopyrazine analogs, are also disclosed.
